Immunofluorescence in dermatology

Journal of the American Academy of Dermatology

Volumn 45, Issue 6, 2001, Pages 803-824

  Mutasim, Diya F ^a   Adams, Brian B ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOIMMUNE DISEASE; BULLOUS SKIN DISEASE; CONNECTIVE TISSUE DISEASE; IMMUNOFLUORESCENCE; PRIORITY JOURNAL; REVIEW; SKIN DEFECT; VASCULITIS;

EID: 0035180362     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2001.117518     Document Type: Article

References (224)

1. Bullous pemphigoid, cicatricial pemphigoid, and pemphigoid gestationis
2. Cicatricial pemphigoid
3. IgA pemphigus foliaceus: Report of two cases and a review of the literature
4. Paraneoplastic pemphigus
5. Anti-type IV collagen antibodies in serum from a patient with sub-epidermal blistering are directed against the α5 (IV) chain
6. The dermal-epidermal junction
7. Brazilian pemphigus foliaceus autoantibodies are pathogenic to BALB/c mice by passive transfer
8. Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease
9. Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion
10. Demonstration of skin antibodies in sera of pemphigus vulgaris patients by indirect immunofluorescent staining
11. Immunomorphological and biochemical identification of the pemphigus foliaceus autoantigen within desmosomes
12. Pemphigus vulgaris antigen, a desmoglein type of cadherin, is localized within keratinocyte desmosomes
13. Cell adhesion molecules as targets of autoantibodies in pemphigus and pemphigoid, bullous diseases due to defective epidermal cell adhesion
14. Identification of pemphigus vulgaris antigen extracted from normal human epidermis and comparison with pemphigus foliaceus antigen
15. End of the century overview of skin blisters
16. Epidermal acantholysis induced in vitro by pemphigus autoantibody
17. Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris
18. Pemphigus and pemphigoid as paradigms of organ-specific, autoantibody-mediated diseases
19. A major role for neutrophils in experimental bullous pemphigoid
20. A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP 180
21. Linear IgA bullous dermatosis and chronic bullous dermatosis of childhood
22. IgA linear dermatosis of childhood (chronic bullous disease of childhood)
23. Paraneoplastic pemphigus: An autoimmune mucocutaneous disease associated with neoplasia
24. Epidermolysis bullosa acquisita presenting as an inflammatory bullous disease
25. Epidermolysis bullosa acquisita: Immunofluorescence, electron microscopic and immunoelectron microscopic studies in four patients
26. Epidermolysis bullosa acquisita: A heterogeneous disease
27. Epidermolysis bullosa acquisita
28. Unusual subepidermal bullous diseases with immunologic features of bullous pemphigoid
29. The spectrum of epidermolysis bullosa acquisita
30. Epidermolysis bullosa acquisita
31. Epidermolysis bullosa acquisita: Report of three cases and review of all published cases
32. Cicatricial pemphigoid
33. Bullous systemic lupus erythematosus: An unusual clinical course and detectable circulating autoantibodies to the epidermolysis bullosa acquisita antigen
34. Epidermolysis bullosa acquisita
35. Vesiculobullous systemic lupus erythematosus
36. Linear IgA bullous dermatosis
37. Linear IgA bullous dermatolosis in adults - The St Mary's view
38. Defined immunofluorescence in immunodermatology
39. The use of human skin for the detection of anti-epithelial autoantibodies: A diagnostic and prognostic test
40. Bullous pemphigoid antibodies: Human skin as a substrate for indirect immunofluorescence assay
41. Monkey esophagus: A unique antigenic substrate in immunodermatology
42. Localization of basement membrane components after dermal-epidermal junction separation
43. Comparison of different epithelial substrates useful for indirect immunofluorescence testing of sera from patients with active pemphigus
44. Comparison of the reactivity of various epithelial substrates for the titration of pemphigus antibodies by indirect immunofluorescence
45. Pemphigus: Superiority of monkey esophagus in the determination of pemphigus antibody
46. Factors contributing to occasional failures in demonstration of pemphigus antibodies by the immunofluorescence test
47. Fate of pemphigus antibody following successful therapy: Preliminary evaluation of pemphigus antibody determinations to regulate therapy
48. Direct immunofluorescent studies of pemphigus and bullous pemphigoid
49. Autoantibodies in pemphigus vulgaris
50. Senear-Usher syndrome (pemphigus erythematosus)
51. Pemphigus foliaceus: Subcorneal intercellular antibodies of unique specificity
52. Pemphigus vulgaris antigen (desmoglein 3) is localized in the lower epidermis,the site of blister formation in patients
53. Classical and alternate pathway activation of complement in pemphigus vulgaris lesions
54. Direct immunofluorescent study of the skin on occurrence of complement in pemphigus
55. Immunopathological investigations in the Senear-Usher syndrome (coexistence of pemphigus and lupus erythematosus)
56. Drug-induced pemphigus
57. Drug-induced pemphigus
58. Drug-induced pemphigus: Autoantibodies directed against the pemphigus antigen complexes are present in penicillamine and captopril induced pemphigus
59. Induction of acantholysis in organ explant culture by penicillamine and captopril
60. The distribution of IgA pemphigus antigen in human skin and the role of IgA anti-cell surface antibodies in the induction of intraepidermal acantholysis
61. Specificity and sensitivity of indirect and direct immunofluorescent findings in the diagnosis of pemphigus
62. Linear immunofluorescence staining of the cutaneous basement membrane zone produced by pemphigoid antibodies: The result of hemidesmosome staining
63. The immunopathology of bullous pemphigoid antibodies
64. Cicatricial pemphigoid: Immunofluorescent studies
65. Ocular cicatricial pemphigoid (immunologic studies)
66. Cicatricial pemphigoid: Immunofluorescent studies
67. Immunofluorescence and immunoelectron microscopic studies in cicatricial pemphigoid
68. Immunofluorescent studies in mucous membrane pemphigoid
69. Cicatricial pemphigoid: Immunofluorescence investigations
70. Cicatricial pemphigoid: Direct and indirect immunofluorescent studies
71. Immunopathology of cicatricial pemphigoid: Studies of complement deposition
72. Benign mucous membrane pemphigoid: Demonstration of circulating and tissue-bound membrane antibodies
73. Herpes gestationis
74. Herpes gestationis: Immunopathological and ultrastructural studies
75. Herpes gestationis: A clinicopathologic study
76. Herpes gestationis: Clinical and histologic features of twenty-eight cases
77. Epidermolysis bullosa acquisita
78. Bullous eruption of systemic lupus erythematosus
79. Bullous systemic lupus erythematosus
80. Systemic lupus erythematosus with vesiculobullous lesions: Immunoelectron microscopic studies
81. Differences in complement-dependent chemotactic activity generated by bullous pemphigoid and epidermolysis bullosa acquisita immune complexes: Demonstration by leukocytic attachment and organ culture methods
82. Pemphigoid antibody mediated attachment of peripheral blood leukocytes at the dermal-epidermal junction of human skin
83. Functional evidence for complement-activating immune complexes in the skin of patients with bullous pemphigoid
84. Evidence that anti-basement membrane zone antibodies in bullous eruption of systemic lupus erythematosus recognize epidermolysis bullosa acquisita autoantigen
85. Linear IgA disease in adults
86. Linear IgA bullous dermatosis: An immunologically defined disease
87. The relationship between linear IgA disease and benign mucous membrane pemphigoid
88. The ultrastructural localization of IgA deposits in chronic bullous disease of childhood (CBDC)
89. Direct immunofluorescence studies of sodium chloride-separated skin in the differential diagnosis of bullous pemphigoid and epidermolysis bullosa acquisita
90. Differentiating anti-lamina lucida and anti-sublamina densa anti-BMZ antibodies by indirect immunofluorescence on 1.0 M sodium chloride separated skin
91. Immunofluorescence on salt-split skin for the diagnosis of epidermolysis bullosa acquisita
92. Ultrastructural localization of immunoglobulins in bullous pemphigoid skin: Employment of a new peroxidase-antiperoxidase multistep method
93. Isolation of a human epidermal cDNA corresponding to the 180-kD autoantigen recognized by bullous pemphigoid and herpes gestationis sera: Immunolocalization of this protein to the hemidesmosome
94. Definition of bullous pemphigoid antibody binding to intracellular and extracellular antigen associated with hemidesmosomes
95. Identification of the skin basement membrane autoantigen in epidermolysis bullosa acquisita
96. Antiepiligrin cicatricial pemphigoid: A subepithelial bullous disorder
97. Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid
98. Levels of antibodies to BP180 correlate with disease activity in bullous pemphigoid
99. Bullous pemphigoid and herpes gestationis autoantibodies recognize a common non-collagenous site on the BP180 ectodomain
100. Cicatricial pemphigoid
101. Cicatricial and localized pemphigoid
102. Ocular involvement in epidermolysis bullosa acquisita
103. Porphyrias
104. Dermatitis herpetiformis
105. Immunofluorescence studies in the diagnosis of dermatitis herpetiformis and its differentiation from bullous pemphigoid
106. Immunoglobulins in the skin in dermatitis herpetiformis and various other skin diseases
107. The pathogenesis of dermatitis herpetiformis
108. Evidence for the activation of complement via the alternate pathway in skin diseases II Dermatitis herpetiformis
109. Granular deposits of immunoglobulins in the skin of patients with dermatitis herpetiformis: An immunofluorescent study
110. Morbilliform eruptions caused by penicillin
111. Pemphigus-like antibodies in bullous pemphigoid
112. Pemphigus-like antibodies in cicatricial pemphigoid
113. Complement-fixing intercellular antibodies in a case of cicatricial pemphigoid
114. Accuracy of indirect immunofluorescence testing in the diagnosis of paraneoplastic pemphigus
115. Pemphigus
116. Correlation of antibodies in skin and serum with disease severity in pemphigus
117. Clinical significance of autoantibodies in pemphigus
118. Subcorneal pustular dermatotis and monoclonal IgA
119. Subcorneal pustular dermatosis with vesiculo-bullous eruption: Demonstration of subcorneal IgA deposits and a leukocyte chemotactic factor
120. Subcorneal pustular dermatosis and IgA grammopathy
121. Intraepidermal neutrophilic IgA dermatosis
122. Aytpical neutrophilic dermatosis with subcorneal IgA deposits
123. Intercellular IgA dermatosis with clinical features of subcorneal pustular dermatosis
124. Pemphigus-like IgA deposits and vesiculo-pustular dermatosis in a 10-year-old girl
125. Intercellular IgA deposition in patients with clinical features of subcorneal pustular dermatosis
126. Intra-epidermal neutrophilic IgA dermatosis with colitis
127. Intraepidermal neutrophilic IgA dermatosis
128. Intercellular IgA dermatosis of childhood
129. IgA pemphigus foliaceus with a clinical presentation of pemphigus herpetiformis
130. Autoantigens for IgA anti-intercellular antibodies of intercellular IgA vesiculopustular dermatosis
131. Basement zone antibodies in bullous pemphigoid
132. Bullous pemphigoid
133. Herpes gestationis
134. Epidermolysis bullosa acquisita: Ultrastructural and immunological studies
135. Antireticulin and antigliadin antibodies in dermatitis herpetiformis and celiac disease
136. Use of antigliadin antibody tests
137. Antiendomysial antibodies in dermatitis herpetiformis and celiac disease
138. Comparison of disease specificity of antiendomysial and antigliadin antibodies
139. The immunopathology of herpes gestationis: Immunofluorescence studies and characterization of "HG factor."
140. Herpes gestationis: Immunopathology and characterization of the HG factor
141. Complement immunofluorescent staining in bullous pemphigoid
142. The complement system in bullous pemphigoid. II. Immunofluorescent evidence for both classical and alternate-pathway activation
143. A practical guide for serologic evaluation of autoimmune connective tissue diseases
144. Direct immunofluorescence in lupus erythematosus
145. Usefulness of direct immunofluorescence in patients with lupus erythematosus
146. Chronic cutaneous lupus erythematosus (DLE): A clinical and laboratory investigation of 80 patients
147. Chronic discoid lupus erythematosus in Thailand: Direct immunofluorescence study
148. Immunofluorescent techniques in clinical diagnosis of cutaneous disease
149. Chronic discoid lupus erythematosus: An immunopathological and electron microscopic study
150. Lupus erythematosus
151. The significance of an IgM band at the dermo-epidermal junction
152. How reliable is the basement membrane phenomenon in the diagnosis of systemic lupus erythematosus?
153. The lupus band test as a measure of disease activity in systemic lupus erythematosus
154. Clinical, histological and immunopathological features of 58 patients with subacute cutaneous lupus erythematosus: A review by the Italian group of immunodermatology
155. Subacute cutaneous lupus erythematosus: A cutaneous marker for a distinct lupus erythematosus subset
156. Clinical, histologic, and immunofluorescent distinctions between subacute cutaneous lupus erythematosus and discoid lupus erythematosus
157. A characteristic cutaneous direct immunofluorescent pattern associated with Ro(SS-A) antibodies in subacute cutaneous lupus erythematosus
158. Mechanisms of cutaneous tissue damage in lupus erythematosus
159. Subacute cutaneous lupus erythematosus
160. Subacute cutaneous lupus erythematosus: Clinicopathologic findings in thirteen cases
161. Subacute cutaneous lupus erythematosus versus systemic lupus erythematosus: Diagnostic criteria and therapeutic implications
162. Subacute cutaneous lupus erythematosus: Genetic markers and clinical and immunological findings in patients
163. Cutaneous manifestations of lupus erythematosus
164. The significance of cutaneous immunoglobulin deposits in lupus erythematosus and NZB/NZW F, hybrid mice
165. Study of cutaneous lupus erythematosus by immunohistochemical methods
166. Characteristics of a soluble nuclear antigen precipitating with sera of patients with systemic lupus erythematosus
167. Demonstration of immunoglobulins and complement in the skin of patients with lupus erythematosus
168. The immunofluorescent "band" test for lupus erythematosus
169. The immunofluorescent "band" test for lupus erythematosus. III. Employing clinically normal skin
170. Immunofluorescent "band" test for lupus erythematosus. H. Employing skin lesions
171. Diagnostic significance of immunohistological skin examination in patients with primary Sjogren's syndrome and other chronic inflammatory connective tissue diseases
172. Clinical significance of laboratory findings in scleroderma
173. Clinical significance of serum properdin levels and properdin deposition in the dermal-epidermal junction in systemic lupus erythematosus
174. A reappraisal of the relationship between subepidermal immunoglobulin deposits and DNA antibodies in systemic lupus erythematosus: A study using the crithidia lucillae immunofluorescence anti-DNA assay
175. Lupus band test
176. Direct immunofluorescence of bullous systemic lupus erythematosus
177. Cutaneous immunopathology: Recent observations
178. The immunofluorescent skin test in systemic lupus erythematosus
179. Incidence of a positive lupus band test using sun-exposed and unexposed skin
180. Immunofluorescence skin test for lupus erythematosus
181. The clinical utility of the lupus band test
182. Immunofluorescent skin band test in the differential diagnosis of systemic lupus erythematosus
183. Immunopathologic investigations in lupus erythematosus
184. Diagnostic evaluation of the lupus band test in discoid and systemic lupus erythematosus
185. Neonatal lupus erythematosus
186. Neonatal lupus erythematosus syndrome
187. Neonatal lupus erythematosus
188. Current concepts in the classification of connective tissue diseases: Overlap syndromes and mixed connective tissue disease (MCTD)
189. Systemic scleroderma localized scleroderma, mixed connective tissue disease
190. Clinicopathological significance of cutaneous epidermal nuclear staining by direct immunofluorescence
191. In vivo antinuclear antibodies (ANA) in biopsies of normal skin: Diagnostic significance and relation to serum ANA
192. Mixed connective tissue disease characterized by speckled epidermal nuclear IgG deposition in normal skin
193. Epidermal IgG deposits in patients with chronic inflammatory connective tissue diseases: Diagnostic value and correlation to clinical and immunological parameters in patients with primary Sjogren's syndrome
194. Immunofluorescence studies in progressive systemic sclerosis (scleroderma) and mixed connective tissue disease
195. Comments on clinical significance of immunologic findings in connective tissue diseases
196. Direct immunofluorescence in the diagnosis of sderoderma syndromes
197. Immunopathologic findings in systemic sclerosis patients: Clinical and immunopathologic relationships
198. Speckled (particulate) epidermal nuclear IgG deposition in normal skin
199. The value of direct immunofluorescence as a diagnostic aid in dermatomyositis: A study of 35 cases
200. Direct and indirect immunofluorescent findings in dermatomyositis
201. Necrotizing vasculitis
202. Immunopathology of blood vessels: Immunopathology of vasculitis
203. Value of skin biopsy in vasculitis
204. Demonstration of immune complexes in spontaneous and histamine-induced lesions and in normal skin of patients with leukocytoclastic angiitis
205. Henoch-Schönlein vasculitis: Direct immunofluorescence study of uninvolved skin
206. Dermal and glomerular deposition of IgA in anaphylactoid purpura
207. IgA deposits in cutaneous blood-vessel walls and mesangium in Henoch-Schönlein syndrome
208. Dermal IgA deposits in Henoch-Schönlein purpura and Berger's nephritis
209. Henoch-Schönlein purpura
210. Lichen planus
211. Lichen planus
212. An immunofluorescence study of lichen planus
213. Cutaneous immunopathology: The diagnostic use of direct and indirect immunofluorescence techniques in dermatologic disease
214. The diagnostic significance of immunoglobulin and fibrin deposition in lichen planus
215. Cutaneous manifestations of complement deficiencies
216. Globular deposits of immunoglobulins and complement in the papillary dermis
217. Hyaline bodies in subepidermal papillae: Immunohistochemical studies in several dermatoses
218. Cutaneous immunofluorescence study of erythema multiforme: Correlation with light microscopic patterns and etiologic agents
219. Erythema multiforme: Clinical, histopathologic, and immunologic study
220. The specificity and clinical usefulness of the lupus band test
221. Lupus band test
222. Erythema multiforme
223. Pyoderma gangrenosum/Sweet's syndrome